Cargando…

Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?

While two influenza B virus lineages have co-circulated, B/Yamagata-lineage circulation has not been confirmed since March 2020. The WHO FluNet database indicates that B/Yamagata-lineage detections were reported in 2021 and 2022. However, detections can result from use of quadrivalent live-attenuate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paget, John, Caini, Saverio, Del Riccio, Marco, van Waarden, Willemijn, Meijer, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2022
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524051/ https://www.ncbi.nlm.nih.gov/pubmed/36177871 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.39.2200753

Ejemplares similares

Extinction of the Influenza B Yamagata Line during the COVID Pandemic—Implications for Vaccine Composition
por: Vajo, Zoltan, et al.
Publicado: (2022)

Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
por: Myers, Mallory L., et al.
Publicado: (2022)

Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
por: Myers, Mallory L., et al.
Publicado: (2023)

Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively
por: Adlhoch, Cornelia, et al.
Publicado: (2018)

Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018
por: Skowronski, Danuta M, et al.
Publicado: (2018)

The Association between Influenza Vaccination and the Risk of SARS-CoV-2 Infection, Severe Illness, and Death: A Systematic Review of the Literature
por: Del Riccio, Marco, et al.
Publicado: (2020)

Letter to the Editor (reply to Souty C et al.): The causes of long‐term trends in the epidemiology of influenza
por: Caini, Saverio, et al.
Publicado: (2019)

Impact of influenza vaccination in the Netherlands, 2007–2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees
por: Caini, Saverio, et al.
Publicado: (2021)

The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21(st) century
por: Caini, Saverio, et al.
Publicado: (2019)

Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020
por: Sullivan, Sheena G, et al.
Publicado: (2020)

The rationale for quadrivalent influenza vaccines
por: Ambrose, Christopher S., et al.
Publicado: (2012)

An Economic Comparison in the Elderly of Adjuvanted Quadrivalent Influenza Vaccine with Recombinant Quadrivalent Influenza Vaccine in Spain
por: Ruiz-Aragón, Jesús, et al.
Publicado: (2023)

Epidemiology and timing of seasonal influenza epidemics in the Asia-Pacific region, 2010–2017: implications for influenza vaccination programs
por: El Guerche-Séblain, Clotilde, et al.
Publicado: (2019)

Letter to the editor: Increase of influenza vaccination coverage rates during the COVID-19 pandemic and implications for the upcoming influenza season in northern hemisphere countries and Australia
por: Del Riccio, Marco, et al.
Publicado: (2021)

Epidemiology of seasonal influenza in the Middle East and North Africa regions, 2010‐2016: Circulating influenza A and B viruses and spatial timing of epidemics
por: Caini, Saverio, et al.
Publicado: (2018)

The spatiotemporal characteristics of influenza A and B in the WHO European Region: can one define influenza transmission zones in Europe?
por: Caini, Saverio, et al.
Publicado: (2017)

The impact of influenza and pneumococcal vaccination on antibiotic use: an updated systematic review and meta-analysis
por: van Heuvel, Lotte, et al.
Publicado: (2023)

Predominance of influenza B/Yamagata lineage viruses in Bulgaria during the 2017/2018 season
por: Korsun, N. S., et al.
Publicado: (2019)

Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014
por: Seleka, Mpho, et al.
Publicado: (2017)

The Epidemiology and Burden of Influenza B/Victoria and B/Yamagata Lineages in Kenya, 2012–2016
por: Emukule, Gideon O, et al.
Publicado: (2019)

Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax(®) Tetra/Flucelvax Quadrivalent(®)): A Review in the Prevention of Influenza
por: Lamb, Yvette N.
Publicado: (2019)

Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden
por: Tisa, V., et al.
Publicado: (2016)

No safety signals for GSK quadrivalent influenza vaccine
Publicado: (2022)

The impact of the SARS‐CoV‐2 pandemic on global influenza surveillance: Insights from 18 National Influenza Centers based on a survey conducted between November 2021 and March 2022
por: Staadegaard, Lisa, et al.
Publicado: (2023)

Correction to: Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax(®) Tetra/Flucelvax Quadrivalent(®)): A Review in the Prevention of Influenza
por: Lamb, Yvette N.
Publicado: (2019)

An Economic Evaluation of the Adjuvanted Quadrivalent Influenza Vaccine Compared with Standard-Dose Quadrivalent Influenza Vaccine in the Spanish Older Adult Population
por: Fochesato, Anna, et al.
Publicado: (2022)

Cross-Lineage Influenza B and Heterologous Influenza A Antibody Responses in Vaccinated Mice: Immunologic Interactions and B/Yamagata Dominance
por: Skowronski, Danuta M., et al.
Publicado: (2012)

Authors’ reply: Geographic resolution of surveillance data and influenza prevention in large countries
por: Caini, Saverio, et al.
Publicado: (2017)

Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017–2018
por: Boikos, Constantina, et al.
Publicado: (2020)

Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19
por: Chiu, Susan S, et al.
Publicado: (2019)

Real-time RT-PCR assays for discriminating influenza B virus Yamagata and Victoria lineages
por: Nakauchi, Mina, et al.
Publicado: (2014)

Important changes in the timing of influenza epidemics in the WHO European Region over the past 20 years: virological surveillance 1996 to 2016
por: Caini, Saverio, et al.
Publicado: (2018)

Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22
por: Martínez-Baz, Iván, et al.
Publicado: (2022)

A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control
por: Ray, Riju, et al.
Publicado: (2017)

Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia
por: Jamotte, Aurélien, et al.
Publicado: (2016)

Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain
por: Ruiz-Aragón, Jesús, et al.
Publicado: (2022)

Clinical characteristics and severity of influenza infections by virus type, subtype, and lineage: A systematic literature review
por: Caini, Saverio, et al.
Publicado: (2018)

Monitoring the mortality impact of COVID-19 in Europe: What can be learned from 2009 influenza H1N1p mortality studies?
por: Staadegaard, Lisa, et al.
Publicado: (2021)

Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
por: Nham, Eliel, et al.
Publicado: (2023)

Surveillance and Vaccine Effectiveness of an Influenza Epidemic Predominated by Vaccine-Mismatched Influenza B/Yamagata-Lineage Viruses in Taiwan, 2011−12 Season
por: Lo, Yi-Chun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g1a295un7gt451eb4o28n2nvio